AstraZeneca , the oncology and biopharmaceutical company, secured a major access win for Enhertu in England after the NHS reversed an ear ...
LONDON — The coronavirus vaccine being developed by AstraZeneca and the University of Oxford was found to be "highly" protective, potentially paving the way for a vaccine that is more affordable and ...
South Africa’s Health Ministry says the decision is based on a trial that found the vaccine offers limited protection for the ...
LONDON, Sept 17 (Reuters) - AstraZeneca and Daiichi Sankyo said on Thursday their breast cancer treatment Enhertu has been ...
LONDON (AP) — AstraZeneca said Monday that late-stage trials showed that its COVID-19 vaccine with Oxford University was up to 90% effective in preventing disease. The results are based on interim ...
The Oxford/AstraZeneca vaccine fails to prevent mild and moderate cases of the South African coronavirus strain, researchers said Sunday. The University of Witwatersrand, Johannesburg, which conducted ...
LONDON, Nov 27 (Reuters) - AstraZeneca's (AZN.L), opens new tab Fasenra, an injectable treatment for severe asthma, is more effective during attacks than the oral steroid that has been the standard of ...